Fresenius Medical Care (FME.DE) Delnica Cena

Fresenius Medical Care Cena

XETRA·ZAPRTO
41,09EUR-1,22 (-2,93 %)
Trg je zaprt

Revenue has compounded at 6,0% per year over the past 19 years to 19,63 Mrd. EUR. Earnings per share have grown at 4,9% per year over the last 19 years. Fresenius Medical Care's net margin stands at 5,0%, broadly stable from 5,5% several years earlier. Fresenius Medical Care currently offers a dividend yield of about 3,50%. The payout ratio is around 42% of earnings. The dividend has grown at 0,8% per year over the past 19 years. Analysts set a median price target of 46,92 EUR, implying 14,2% above the current price. Of 27 analysts, 11 rate the stock a buy — an overall Hold consensus. The stock trades about 18% above its 52-week low.

Cena delnice Fresenius Medical Care

Obseg
Ex-dividenda
Podrobnosti

Cena delnice

ⓘ

Kako prebrati ta grafikon

Ta grafikon sledi zgodovinski ceni delnice Fresenius Medical Care skozi čas. Lahko preklapljate med dnevnimi, tedenskimi in mesečnimi prikazi ter izberete prilagojene časovne intervale – od enega dne do celotne razpoložljive zgodovine. Uporabite stikalo za prikaz sprememb cen v absolutnih valutnih pogojih ali kot odstotna sprememba glede na začetni datum.

Skupni prinos v primerjavi s cenovnim prinosom

Stikalo "Skupni prinos" vključuje reinvestirane dividende na vrh čistega gibanja cene. To je kritično, ker lahko dividende predstavljajo pomemben del dolgoročnih prinosov. Zgodovinsko so dividende predstavljale približno 40 % skupnega prihoda S&P 500. Vedno primerjajte skupni prinos pri vrednotenju prave zmogljivosti delnice glede na referenčni indeks.

Podatki o cenah v realnem času

Pri pregledu časovnega okvira enega dne grafikon prikazuje gibanja cen v realnem času intraday. To je koristno za opazovanje, kako se delnica Fresenius Medical Care odziva na odpiranje trga, objave dobičkov ali novice v realnem času med trgovalno sejo.

Kaj iskati

Poglejte si dolgoročne trende (trajnostna gibanja navzgor ali navzdol v mesecih in letih), podporne in odporne ravni (cenovne cone, kjer se delnica ponavljajoče odbija ali spreminja smer) in volatilnost (kako se cena nihanja dan za dnem). Primerjava grafikona cene Fresenius Medical Care z indeksom trga, kot je S&P 500, lahko razkrije, ali delnica presega ali zaostaja za širšim trgom.

Fresenius Medical Care Zgodovina cene delnice
DatumFresenius Medical Care Cena
12. 8. 202641,09 EUR
10. 8. 202642,31 EUR
7. 8. 202642,05 EUR
6. 8. 202641,88 EUR
5. 8. 202641,31 EUR
4. 8. 202641,34 EUR
31. 7. 202644,45 EUR
30. 7. 202643,93 EUR
29. 7. 202643,58 EUR
28. 7. 202643,19 EUR
27. 7. 202643,88 EUR
24. 7. 202643,27 EUR
23. 7. 202642,43 EUR
22. 7. 202642,74 EUR
21. 7. 202643,28 EUR
20. 7. 202642,27 EUR
17. 7. 202641,87 EUR
16. 7. 202642,05 EUR
15. 7. 202642,12 EUR
14. 7. 202642,40 EUR
13. 7. 202642,37 EUR
10. 7. 202641,93 EUR
9. 7. 202641,84 EUR
8. 7. 202641,94 EUR
7. 7. 202642,29 EUR
6. 7. 202641,19 EUR
3. 7. 202640,98 EUR
2. 7. 202641,15 EUR
1. 7. 202640,09 EUR
30. 6. 202639,60 EUR
29. 6. 202639,56 EUR
26. 6. 202640,86 EUR
25. 6. 202640,89 EUR
24. 6. 202642,15 EUR
23. 6. 202641,55 EUR
22. 6. 202641,25 EUR
19. 6. 202640,97 EUR
18. 6. 202640,97 EUR
17. 6. 202640,73 EUR
16. 6. 202640,65 EUR
15. 6. 202640,41 EUR
12. 6. 202639,54 EUR
11. 6. 202638,92 EUR
10. 6. 202638,90 EUR
9. 6. 202638,63 EUR
8. 6. 202637,87 EUR
5. 6. 202638,14 EUR
4. 6. 202637,04 EUR
3. 6. 202635,63 EUR
2. 6. 202636,15 EUR
1. 6. 202636,43 EUR
29. 5. 202637,54 EUR
28. 5. 202636,59 EUR
27. 5. 202637,41 EUR
26. 5. 202637,68 EUR
25. 5. 202637,45 EUR
22. 5. 202637,02 EUR
21. 5. 202638,97 EUR
20. 5. 202638,21 EUR
19. 5. 202638,34 EUR
18. 5. 202638,12 EUR
15. 5. 202637,22 EUR
14. 5. 202636,86 EUR
13. 5. 202636,53 EUR
12. 5. 202637,66 EUR
11. 5. 202637,27 EUR
8. 5. 202637,34 EUR
7. 5. 202637,20 EUR
6. 5. 202635,83 EUR
5. 5. 202634,72 EUR
4. 5. 202638,87 EUR
30. 4. 202638,61 EUR
29. 4. 202638,07 EUR
28. 4. 202638,71 EUR
27. 4. 202638,75 EUR
24. 4. 202638,84 EUR
23. 4. 202639,01 EUR
22. 4. 202639,20 EUR
21. 4. 202639,60 EUR
20. 4. 202639,43 EUR
17. 4. 202639,57 EUR
16. 4. 202638,95 EUR
15. 4. 202638,69 EUR
14. 4. 202639,65 EUR
13. 4. 202640,02 EUR
10. 4. 202640,34 EUR
9. 4. 202640,04 EUR
8. 4. 202640,25 EUR
7. 4. 202639,50 EUR
2. 4. 202638,47 EUR
27. 3. 202639,41 EUR
26. 3. 202638,48 EUR
24. 3. 202637,94 EUR
23. 3. 202637,50 EUR
20. 3. 202637,64 EUR
19. 3. 202638,74 EUR
17. 3. 202640,02 EUR
16. 3. 202640,22 EUR
13. 3. 202639,78 EUR
12. 3. 202639,81 EUR
11. 3. 202639,93 EUR
10. 3. 202639,13 EUR
6. 3. 202639,72 EUR
5. 3. 202639,60 EUR
27. 2. 202639,43 EUR
26. 2. 202639,08 EUR
25. 2. 202638,34 EUR
23. 2. 202641,49 EUR
20. 2. 202641,07 EUR
19. 2. 202641,07 EUR
18. 2. 202640,54 EUR
17. 2. 202641,37 EUR
16. 2. 202640,94 EUR
14. 2. 202641,01 EUR
12. 2. 202639,92 EUR
11. 2. 202640,13 EUR
10. 2. 202640,21 EUR
9. 2. 202639,72 EUR
6. 2. 202640,57 EUR
5. 2. 202640,66 EUR
4. 2. 202640,16 EUR
3. 2. 202639,00 EUR
2. 2. 202638,11 EUR
30. 1. 202637,61 EUR
29. 1. 202637,42 EUR
28. 1. 202637,27 EUR
26. 1. 202637,34 EUR
23. 1. 202637,18 EUR
22. 1. 202637,38 EUR
21. 1. 202636,11 EUR
20. 1. 202635,99 EUR
19. 1. 202636,93 EUR
16. 1. 202637,28 EUR
14. 1. 202637,14 EUR
13. 1. 202639,73 EUR
12. 1. 202640,72 EUR
9. 1. 202639,49 EUR
8. 1. 202639,01 EUR
7. 1. 202639,65 EUR
6. 1. 202640,26 EUR
5. 1. 202640,36 EUR
2. 1. 202640,09 EUR
30. 12. 202540,73 EUR
29. 12. 202540,84 EUR
23. 12. 202540,80 EUR
22. 12. 202540,69 EUR
19. 12. 202540,22 EUR
18. 12. 202540,29 EUR
17. 12. 202540,32 EUR
16. 12. 202540,36 EUR
15. 12. 202540,41 EUR
12. 12. 202540,06 EUR
11. 12. 202539,90 EUR
10. 12. 202539,82 EUR
8. 12. 202539,53 EUR
5. 12. 202540,12 EUR
4. 12. 202540,73 EUR
3. 12. 202540,45 EUR
2. 12. 202540,90 EUR
1. 12. 202540,97 EUR
28. 11. 202541,20 EUR
27. 11. 202541,16 EUR
26. 11. 202541,28 EUR
25. 11. 202541,59 EUR
24. 11. 202541,15 EUR
21. 11. 202539,61 EUR
20. 11. 202539,81 EUR
19. 11. 202539,52 EUR
18. 11. 202539,61 EUR
17. 11. 202540,17 EUR
14. 11. 202540,45 EUR
13. 11. 202540,85 EUR
12. 11. 202541,63 EUR
10. 11. 202541,14 EUR
7. 11. 202541,46 EUR
6. 11. 202541,76 EUR
5. 11. 202541,92 EUR
4. 11. 202542,77 EUR
3. 11. 202545,91 EUR
31. 10. 202547,53 EUR
30. 10. 202546,94 EUR
29. 10. 202546,89 EUR
28. 10. 202546,51 EUR
27. 10. 202546,69 EUR
25. 10. 202547,09 EUR
23. 10. 202546,61 EUR
22. 10. 202547,04 EUR
21. 10. 202546,65 EUR
20. 10. 202546,65 EUR
17. 10. 202546,34 EUR
16. 10. 202546,45 EUR
15. 10. 202546,03 EUR
14. 10. 202547,34 EUR
13. 10. 202547,16 EUR
10. 10. 202547,41 EUR
9. 10. 202547,36 EUR
8. 10. 202548,07 EUR
7. 10. 202545,93 EUR
6. 10. 202545,72 EUR
3. 10. 202545,43 EUR
2. 10. 202545,52 EUR
1. 10. 202544,86 EUR
30. 9. 202544,66 EUR
29. 9. 202543,92 EUR
26. 9. 202543,67 EUR
25. 9. 202543,12 EUR
24. 9. 202544,66 EUR
23. 9. 202543,85 EUR
22. 9. 202543,06 EUR
19. 9. 202543,27 EUR
18. 9. 202543,30 EUR
17. 9. 202543,36 EUR
16. 9. 202542,51 EUR
15. 9. 202542,20 EUR
12. 9. 202542,50 EUR
11. 9. 202542,79 EUR
10. 9. 202542,55 EUR
9. 9. 202542,84 EUR
8. 9. 202542,42 EUR
5. 9. 202541,95 EUR
4. 9. 202541,80 EUR
3. 9. 202541,97 EUR
2. 9. 202542,09 EUR
1. 9. 202544,16 EUR
29. 8. 202543,67 EUR
28. 8. 202543,27 EUR
27. 8. 202543,27 EUR
26. 8. 202543,68 EUR
25. 8. 202543,65 EUR
22. 8. 202543,59 EUR
21. 8. 202543,43 EUR
20. 8. 202543,28 EUR
19. 8. 202543,08 EUR
18. 8. 202542,73 EUR
15. 8. 202542,79 EUR
14. 8. 202542,63 EUR
13. 8. 202542,07 EUR
Access this data via the Eulerpool API
Get Free API Key

Fresenius Medical Care Prihodek, EBIT, Neto dobiček

  • 3 leta

  • 5 let

  • 10 let

  • 25 let

  • Največ

Prihodek
EBIT
Neto dobiček
Details
Date
Prihodek
EBIT
Neto dobiček
1. jan. 2023
19,45 Mrd. EUR
1,37 Mrd. EUR
499,00 Mio. EUR
1. jan. 2024
19,34 Mrd. EUR
1,39 Mrd. EUR
537,91 Mio. EUR
1. jan. 2025
19,63 Mrd. EUR
1,83 Mrd. EUR
978,00 Mio. EUR
1. jan. 2026 (e)
19,36 Mrd. EUR
1,60 Mrd. EUR
1,17 Mrd. EUR
1. jan. 2027 (e)
20,05 Mrd. EUR
1,66 Mrd. EUR
1,28 Mrd. EUR
1. jan. 2028 (e)
20,88 Mrd. EUR
1,73 Mrd. EUR
1,46 Mrd. EUR
1. jan. 2029 (e)
21,68 Mrd. EUR
1,80 Mrd. EUR
1,73 Mrd. EUR
1. jan. 2030 (e)
22,62 Mrd. EUR
1,87 Mrd. EUR
1,92 Mrd. EUR

Fresenius Medical Care Izkaz poslovnega izida, Bilanca stanja, Izkaz denarnih tokov

Zadnja posodobitev 12. avg. 2026, 23:44
 
PRIHODKIMrd. EUR
RAST PRIHODKOV%
BRUTTOMARJA%
BRUTO DOHODEKMrd. EUR
EBITMrd. EUR
EBIT MARJA%
ČISTI DOHODEKMrd. EUR
RAST ČISTEGA DOBIČKA%
DIV.EUR
DIV. RAST%
DELNICEMio.
20162017201820192020202120222023202420252026e2027e2028e2029e2030e2031e
17,0317,7816,5517,4817,8617,6219,4019,4519,3419,6319,3620,0520,8821,6822,6224,26
11,244,43−6,965,622,19−1,3410,100,28−0,611,52−1,383,604,093,874,327,23
32,2733,7631,1530,8731,0028,8227,3725,3224,6025,6225,6225,6225,6225,6225,6225,62
5,506,005,165,405,545,085,314,934,765,034,965,145,355,565,806,21
2,512,363,040,710,530,301,541,371,391,831,601,661,731,801,87–
14,7313,2818,364,062,961,717,927,047,209,308,298,288,288,288,28–
1,181,281,981,201,160,970,670,500,540,981,171,281,461,731,921,95
25,508,3854,84−39,46−3,00−16,75−30,55−26,007,8382,1219,639,3214,3918,3911,091,20
0,800,961,061,171,202,691,351,121,191,441,491,551,61–––
2,5620,0010,4210,382,56124,17−49,81−17,046,2521,013,474,033,87–––
306,18306,91306,86299,30292,86293,00293,41293,41293,41285,91285,91285,91285,91285,91285,91285,91
Podrobnosti

Ključne številke izkaza poslovnega izida

ⓘ

Prihodki in rast prihodkov

Prihodki so izhodišče vsakega izkaza poslovnega izida — merijo skupne prodaje, ki jih Fresenius Medical Care ustvari iz svoje osnovne dejavnosti. Rast prihodkov (izražena kot sprememba v odstotkih od leta do leta) je eden od najpomembnejših kazalnikov poslovnega zagona. Trajnostna rast nad 10 % letno se šteje za močno, medtem ko padajoči prihodki predstavljajo resno opozorilo, ki zahteva preiskavo.

Bruto marža

Bruto marža = (Prihodki − Stroški prodanih blaga) ÷ Prihodki. Razkriva, kolikšen odstotek vsakega dolarja prihodkov Fresenius Medical Care zadrži po neposrednih proizvodnih stroških. Visoke bruto marže (nad 50 %) so značilne za poslovanja z majhno količino sredstev, kot so programska oprema in blagovne znamke, medtem ko kapitalno intenzivne industrije, kot je proizvodnja, pogosto delujejo z manj kot 30 %. Primerjajte bruto marzho Fresenius Medical Care s konkurenti v industriji in jo spremljajte skozi čas, da ugotovite izboljšano ali poslabšano cenovno moč.

EBIT in marža EBIT

EBIT meri operativni dobiček — tisto, kar ostane po odbitku vseh operativnih stroškov (vključno s stroški R&R, prodaje in administracije) od bruto dobička. Marža EBIT to prikaže kot odstotek prihodkov. Ker izključuje obresti in davke, EBIT omogoča poštene primerjave med podjetji z različnimi ravnmi dolga in davčnimi pristojnosti. Naraščajoča marža EBIT kaže na izboljšano operativno učinkovitost.

Neto dohodek in dobiček na delnico (EPS)

Neto dohodek je končni dobiček podjetja po vseh stroških, obrestih in davkih. Deljenje neto dohodka s številom Outstanding delnic vam daje EPS — en sam najbolj vpliven metriko pri vrednotenju delnic. Dosledna rast EPS je glavni pogon dolgoročnega rasta cene delnice. Vedno preverite, ali rast EPS izvira iz resničnega izboljšanja dobička ali iz odkupa delnic, ki zmanjšuje število delnic.

Izdane delnice

Skupno število delnic, ki jih je Fresenius Medical Care izdal. Padajoče število delnic (preko odkupa) dviguje EPS in signalizira zaupanje managementa. Naraščajoče število delnic (preko izdaje delnic) razvodnjuje obstoječe lastnike. Vedno spremljajte to število skupaj z EPS, da dobite celovito sliko ustvarjanja vrednosti na delnico.

Ocene analitikov

Projicirane številke predstavljajo soglasne ocene strokovnih analitikov. Primerjajte te napovedi z zgodovinskim stopnjami rasti Fresenius Medical Care, da ocenite, ali so pričakovanja realistična. Podjetje, ki dosledno presega soglasne ocene, ima svoje delnice nagrajene skozi čas, medtem ko se ponovljeni zamiki bremenijo zaupanja vlagateljev.

Fresenius Medical Care robni dobički delnice

Analiza Fresenius Medical Care marge prikazuje bruto maržo, maržo EBIT ter dobičkovno maržo Fresenius Medical Care. Marža EBIT (EBIT/prodaja) označuje, kolikšen odstotek prodaje ostane kot operativni dobiček. Dobičkovna marža kaže, kolikšen odstotek prodaje ostane za Fresenius Medical Care.

  • 3 leta

  • 5 let

  • 10 let

  • 25 let

  • Največ

Bruto marža
Marža EBIT
Dobičkovna marža
Details
Date
Bruto marža
Marža EBIT
Dobičkovna marža
1. jan. 2021
28,82 %
1,71 %
5,50 %
1. jan. 2022
27,37 %
7,93 %
3,47 %
1. jan. 2023
25,32 %
7,04 %
2,57 %
1. jan. 2024
24,60 %
7,20 %
2,78 %
1. jan. 2025
25,62 %
9,31 %
4,98 %
1. jan. 2026 (e)
25,62 %
8,29 %
6,04 %
1. jan. 2027 (e)
25,62 %
8,29 %
6,38 %
1. jan. 2028 (e)
25,62 %
8,29 %
7,01 %

Fresenius Medical Care Prihodek na delnico, EBIT, Dobiček na delnico

Fresenius Medical Care dobiček na delnico torej kaže, koliko prihodka je Fresenius Medical Care ustvaril na delnico v danem obdobju. Dobiček pred obrestmi in davki na delnico kaže, koliko operativnega dobička spada v vsako delnico. Dobiček na delnico kaže, koliko dobička spada v vsako delnico.

  • 3 leta

  • 5 let

  • 10 let

  • 25 let

  • Največ

Prihodek na delnico
EBIT na delnico
Dobiček na delnico
Details
Date
Prihodek na delnico
EBIT na delnico
Dobiček na delnico
1. jan. 2021
60,13 EUR
1,03 EUR
3,31 EUR
1. jan. 2022
66,11 EUR
5,24 EUR
2,30 EUR
1. jan. 2023
66,30 EUR
4,67 EUR
1,70 EUR
1. jan. 2024
65,90 EUR
4,75 EUR
1,83 EUR
1. jan. 2025
68,65 EUR
6,39 EUR
3,42 EUR
1. jan. 2026 (e)
65,97 EUR
5,61 EUR
3,99 EUR
1. jan. 2027 (e)
68,35 EUR
5,81 EUR
4,36 EUR
1. jan. 2028 (e)
71,15 EUR
6,05 EUR
4,99 EUR

Fresenius Medical Care poslovni model in analiza delnice

Fresenius Medical Care AG is a globally leading company in the field of dialysis and kidney care. The company was founded in 1996 when Fresenius AG merged its dialysis business with the US company National Medical Care (NMC). Today, Fresenius Medical Care operates in over 120 countries and employs around 120,000 people. The company operates more than 3,900 dialysis centers worldwide and serves approximately 345,000 dialysis patients. The business model of Fresenius Medical Care aims to improve the lives of patients with chronic kidney diseases by offering high-quality dialysis treatments, kidney care products, and treatment technologies. Fresenius Medical Care provides its patients with a comprehensive range of products and services that range from diagnosis to treatment and enable individualized patient care. A core competency of Fresenius Medical Care is the development and manufacture of dialysis products and technologies. The company offers a wide range of dialysis machines and accessories that can be used to support dialysis care in hospitals, clinics, and dialysis centers. In addition, the company offers medical solutions tailored to the needs of dialysis patients, including artificial kidneys, dialysis filters, and other medical devices. Fresenius Medical Care also conducts extensive research and development activities to develop innovative technologies as well as products and services that can improve the lives of dialysis patients. In terms of diagnostic products, Fresenius Medical Care offers a variety of laboratory and testing solutions that are used to monitor dialysis patients and ensure timely diagnosis of complications and infections. The company also offers a comprehensive range of medical devices and accessories that can be used to support patients in home dialysis. Fresenius Medical Care operates in three business segments: dialysis products, dialysis services, and hospital products. In the dialysis products segment, the company is engaged in the development, manufacture, and distribution of dialysis machines and accessories. In the dialysis services segment, the company operates a variety of dialysis centers and provides dialysis treatments performed by a multidisciplinary team of professionals. The company also operates a network of laboratories that offer diagnostic solutions for dialysis patients. In the hospital products segment, Fresenius Medical Care offers a variety of medical devices and solutions that help improve the clinical care of patients, including apheresis systems, infusion systems, and patient monitors. Throughout its history, Fresenius Medical Care has received numerous awards and recognitions, including the Innovation Award of the state of Baden-Württemberg for the development of an automated dialysis machine that enables better treatment of dialysis patients through the combination of online monitoring systems and intelligent algorithms. Overall, Fresenius Medical Care AG offers a comprehensive range of products and services for dialysis patients and is a significant player in the field of kidney care. The company is committed to improving the quality of life for patients with chronic kidney diseases and driving the development of innovative technologies and methods to treat this disease.

Fresenius Medical Care vrednotenje po pošteni vrednosti

Podrobnosti

Ocena poštene vrednosti

ⓘ

Kaj je poštena vrednost?

Poštena vrednost je ocena prave "vrednosti" delnice na podlagi njenih finančnih temeljnih podatkov, neodvisno od trenutne tržne cene. Če je izračunana poštena vrednost višja od trenutne cene delnice, je delnica lahko podocenjena — in obratno. Ta grafikon prikazuje tri različne pristope poštene vrednosti, tako da jih lahko medsebojno primerjate.

Poštena vrednost na podlagi dobitka

Izračuna se z množenjem trenutnega dobitka na delnico (EPS) s povprečnim zgodovinskim razmerjem cena/dobiček v izbranem večletnem obdobju. Glajenje v več letih odpravlja začasne konice ali padce. Če ta poštena vrednost presega tržno ceno, to nakazuje, da je delnica poceni v primerjavi z njeno sposobnostjo ustvarjanja dobička.

Primer: Poštena vrednost (dobiček) 2022 = EPS 2022 × Povprečno razmerje KGV 2019–2021

Poštena vrednost na podlagi prihodka

Izpeljana z množenjem prihodka na delnico s povprečnim zgodovinskim razmerjem cena/prodaja. Ta metoda je posebej uporabna za podjetja s spremenljivim ali začasno zmanjšanim dobitkom, saj je prihodek ponavadi bolj stabilen kot dobiček. Odgovarja: "Po kakšni ceni je trg v preteklosti vrednoval vsak dolar prodaje tega podjetja?"

Primer: Poštena vrednost (prihodek) 2022 = Prihodek na delnico 2022 × Povprečno razmerje KUV 2019–2021

Poštena vrednost na podlagi dividende

Izračuna se z deljenjem dividende na delnico s povprečno zgodovinsko donosnostjo dividend. Ta pristop je najbolj relevantan za zrela, dosledno dividende izplačujoča podjetja. Če je dobljena poštena vrednost višja od trenutne cene, to pomeni, da delnica ponuja boljšo donosnost kot njeno zgodovinsko povprečje.

Primer: Poštena vrednost (dividenda) 2022 = Dividenda na delnico 2022 ÷ Povprečna donosnost 2019–2021

Kako uporabljati ta grafikon

Kadar se vse tri črte poštene vrednosti zbližajo nad trenutno ceno, je to okrepitev primera, da je delnica podocenjena. Kadar se razhajajo, preiskati, zakaj — morda gre za strukturni premik v robnih dobičkih, politiki izplačil ali stopnji rasti. Napredne ocene na desni razširijo analizo z uporabo napovedanih temeljnih podatkov, kar vam pomaga oceniti, ali trenutna cena že odraža pričakovanja prihodnje rasti.

Fresenius Medical Care vrednotenje po zgodovinskem razmerju cena-dobiček, večkrtniku EBIT in razmerju cena-prihodki

Fresenius Medical Care letna donosnost

Podrobnosti

Letna donosnost

ⓘ

Kaj prikazuje ta grafikon

Ta grafikon razdeli skupno letno donosnost v dve komponenti: donosnost cene (dobički ali izgube iz gibanja cene delnice) in donosnost dividende (dohodek prejeto od izplačil dividend). Skupaj predstavljajo skupno donosnost, ki bi jo je vlagatelj zaslužil v vsakem koledarskem letu.

Donosnost cene

Donosnost cene meri odstotnino spremembe cene delnice od 1. januarja do 31. decembra vsakega leta. Pozitivne črte nakazujejo, da se je delnica podražila; negativne črte kažejo padec. To je komponenta, na katero se večina vlagateljev osredotoča, vendar le delno pripoveduje zgodbo — posebej za delnice, ki izplačujejo dividende.

Donosnost dividende

Donosnost dividende predstavlja dohodek, ustvarjen z dividendami, izplačanimi v letu, izraženo kot odstotek začetne cene delnice. Čeprav se lahko zdi majhna v kateremkoli letu (navadno 1–4 % za uveljavljenih podjetij), se dividende sčasoma sestavljajo in so zgodovinsko prispevale približno 40 % skupne donosnosti borznega trga.

Kaj poiskati

Preglejte, koliko let je bilo pozitivnih nasproti negativnim donosnostim, da bi ocenili doslednost. Delnica, ki ima večino let s pozitivnimi rezultati in majhnimi upadi, nakazuje manjše tveganje. Primerjajte tudi letno donosnost s primerjalnim indeksom — dosledna preseganja trga je značilnost močne naložbe. Obratite pozornost na najslabša leta: razumevanje tveganja padca je enako pomembno kot lovljenje potenciala rasti.

Fresenius Medical Care izdane delnice

Število delnic podjetja Fresenius Medical Care je bilo 285,91 Mio. v letu 2025. To kaže, na koliko delnic je razdeljeno Fresenius Medical Care. Ker so delničarji lastniki podjetja, vsaka delnica predstavlja majhen del lastništva podjetja.

  • 3 leta

  • 5 let

  • 10 let

  • 25 let

  • Največ

Število delnic
Details
Date
Število delnic
1. jan. 2021
293,00 Mio. Delnice
1. jan. 2022
293,41 Mio. Delnice
1. jan. 2023
293,41 Mio. Delnice
1. jan. 2024
293,41 Mio. Delnice
1. jan. 2025
285,91 Mio. Delnice
1. jan. 2026 (e)
285,91 Mio. Delnice
1. jan. 2027 (e)
285,91 Mio. Delnice
1. jan. 2028 (e)
285,91 Mio. Delnice

Fresenius Medical Care Delitve delnic

V zgodovini Fresenius Medical Care še ni bilo delitev delnic.

Fresenius Medical Care Zgodovina Dividend

28 let izplačil dividend · 2 zaporednih povečanj

LetoLetna DividendaSprememba glede na lansko letoIzplačila
20251,44EUR↑ 21,0%1×
23. maj 20251,44EUR↑ 21,0%1/1
20241,19EUR↑ 6,2%1×
20231,12EUR↓ 17,0%1×
20221,35EUR↓ 49,8%1×
20212,69EUR↑ 124,2%2×
20201,20EUR↑ 2,6%1×
20191,17EUR↑ 10,4%1×
20181,06EUR↑ 10,4%1×
20170,96EUR↑ 20,0%1×
20160,80EUR↑ 2,6%1×

Zgodovina in napovedi dividend Fresenius Medical Care

Leta 2025 je Fresenius Medical Care izplačal dividendo v višini 1,44 EUR. Dividenda pomeni, da Fresenius Medical Care razdelijo del svojih dobičkov lastnikom.

  • 3 leta

  • 5 let

  • 10 let

  • 25 let

  • Največ

Dividenda
Dividenda (ocena)
Details
Date
Dividenda
Dividenda (ocena)
1. jan. 2021
2,69 EUR
0,00 EUR
1. jan. 2022
1,35 EUR
0,00 EUR
1. jan. 2023
1,12 EUR
0,00 EUR
1. jan. 2024
1,19 EUR
0,00 EUR
1. jan. 2025
1,44 EUR
0,00 EUR
1. jan. 2026 (e)
0,00 EUR
1,49 EUR
1. jan. 2027 (e)
0,00 EUR
1,55 EUR
1. jan. 2028 (e)
0,00 EUR
1,61 EUR

Fresenius Medical Care razmerje izplačevanja dividend

Leta 2025 je imela Fresenius Medical Care razmerje izplačila 42,10%. Razmerje izplačila kaže, kolikšen odstotek dobička podjetja Fresenius Medical Care izplača kot dividende.

  • 3 leta

  • 5 let

  • 10 let

  • 25 let

  • Največ

Razmerje izplačila
Details
Date
Razmerje izplačila
1. jan. 2021
81,31 %
1. jan. 2022
58,82 %
1. jan. 2023
65,86 %
1. jan. 2024
64,91 %
1. jan. 2025
42,10 %
1. jan. 2026 (e)
37,45 %
1. jan. 2027 (e)
35,52 %
1. jan. 2028 (e)
32,21 %

Trenutne Fresenius Medical Care napovedi in ciljne cene v Avgust 2026

Cenovna tarča analitikov 2026
Δ Ciljna cena v primerjavi s prejšnjim mesecem
4,66 %
Kupi
40,74 % (11)
Drži
33,33 % (9)
Prodaj
25,93 % (7)
12M Ciljna cena
46,92
Zadnja cena
42,31
Valuta
EUR
12M Potencial donosnosti
10,90 %
Donos LTM
0 %

Fresenius Medical Care Analyst Rating Actions

DateFirmActionRatingReliability
10. 10. 2023
Truist Securities
Truist Securities
MaintainedHold–
12. 7. 2023
Truist Securities
Truist Securities
MaintainedHold–
9. 5. 2023
Truist Securities
Truist Securities
MaintainedHold–
12. 4. 2023
Truist Securities
Truist Securities
MaintainedHold–
22. 2. 2023
Truist Securities
Truist Securities
MaintainedHold–
21. 6. 2022
Truist Securities
Truist Securities
MaintainedHold–
23. 11. 2021
HSBC
HSBC
MaintainedHold–
17. 11. 2021
RBC Capital
RBC Capital
MaintainedSector PerformPerform52
16. 11. 2021
RBC Capital
RBC Capital
MaintainedSector Perform52
10. 11. 2021
Jefferies
Jefferies
UpgradeUnderperformHold47

Eulerpool Reliability Score (0–100): measures how often a firm’s bullish or bearish calls were directionally correct three months later, blended with the average return following its calls. Every rating we record is stored permanently and scores update continuously; firms with fewer than 3 measured calls are not scored yet.

Fresenius Medical Care Sporočila o donosu

2025

Fresenius Medical Care Ocene dobička in presenečenja

DatumOcena EPSDejanski EPSOcena prihodkovOdziv delniceČetrtletno poročilo
20. 2. 20230,69EUR-5,28 Mrd.EUR-2022 Q4
30. 10. 20220,68EUR-5,12 Mrd.EUR-2022 Q3
28. 7. 20220,83EUR-4,84 Mrd.EUR-2022 Q2
4. 5. 20220,70EUR-4,54 Mrd.EUR-2022 Q1
22. 2. 20220,88EUR-4,68 Mrd.EUR-2021 Q4
2. 11. 20210,92EUR-4,54 Mrd.EUR-2021 Q3
30. 7. 20210,76EUR-4,38 Mrd.EUR-2021 Q2
6. 5. 20210,80EUR-4,29 Mrd.EUR-2021 Q1
23. 2. 20211,21EUR-4,52 Mrd.EUR-2020 Q4
29. 10. 20201,16EUR-4,46 Mrd.EUR-2020 Q3
...

EESG©

Eulerpool ESG Scorecard© za delnico Fresenius Medical Care

81/100
70
Environment
86
Social
88
Governance
E

Okolje

20
Neposredne emisije360.803
Posredne emisije iz kupljene energije450.611
Posredne emisije znotraj verige vrednosti.2.993.388
Emisije CO₂811.414
Strategija zmanjšanja CO₂
Ogljična energija
Atomkraft
Poskusi na živalih
Pelz & Leder
Pesticidi—
Palmovo olje
Tobak
Genska tehnologija
Klimatski koncept—
Trajnostno gozdarstvo—
Predpisi o recikliranju
Okolju prijazna embalaža
Nevarne snovi
Poraba goriva in učinkovitost
Poraba vode in učinkovitost
S

Socialni vidiki

20
Odstotek ženskerih zaposlenih70
Odstotek žensk v vodstvu—
Odstotek azijskih zaposlenih—
Delež azijskega vodstva—
Odstotek hispanskih/latinoameriških zaposlenih—
Delež špansko/latinoameriško vodstva—
Odstotek črnih zaposlenih—
Delež črnega vodstva—
Odstotek belih zaposlenih—
Delež belega vodstva—
Vsebina za odrasle
Alkohol
obramba—
orožje
igralništvo
vojaške pogodbe
Koncept človekovih pravic
Koncept zaščite podatkov—
Varnost in zdravje pri delu
Katoliški
G

Korporativno upravljanje

4
Porocilo o trajnostnem razvoju
Vključevanje deležnikov
Pravilnik o odpoklicu
Antitrustna zakonodaja

Eulerpool ESG Scorecard© je strogo zaščitena intelektualna lastnina Eulerpool Research Systems. Vsaka nepooblaščena uporaba, posnemanje ali kršitev bo aktivno pregonjena in lahko vodi do resnih pravnih posledic. Za licence, sodelovanja ali pravice do uporabe nas prosimo kontaktirajte neposredno prek našega Obrazec za kontakt do nas.

Struktura lastnikov delnic Fresenius Medical Care

% Ime
0,00310%
GENERALI INVESTMENTS CEE, INVESTICNI SPOLECNOST, A.S.
GENERALI INVESTMENTS CEE, INVESTICNI SPOLECNOST, A.S.

Fresenius Medical Care Beneficial Ownership Filings (SEC 13D/G)

Free Float
68,4%
Float Shares
-
Shares Outstanding
-

Fresenius Medical Care Uprava in upravni odbor

18 members · avg. age 57 · 39 % women

HG

Ms. Helen Giza (57)

Chairman of the Management Board, Chief Executive Officer

4,44 Mio. EUR

Management

CC

Mr. Craig Cordola (54)

Member of the Management Board, Chief Executive Officer - Care Delivery

3,72 Mio. EUR
KM

Dr. Katarzyna Mazur-Hofsaess (62)

Member of the Management Board, Chief Executive Officer - Care Enablement

3,28 Mio. EUR
FM

Dr. Frank Maddux (68)

Member of the Management Board, Global Chief Medical Officer

2,76 Mio. EUR
MF

Mr. Martin Fischer (49)

Chief Financial Officer, Member of the Management Board

2,52 Mio. EUR
DH

Dr. Dominik Heger

Head of Investor Relations, Strategic Development and Communications, EVP · od 2019

–

Board of Directors

JH

Dr. Joerg Haering (55)

Member of the Management Board - Legal, Compliance, Human Resources and Labor Relations Director

1,38 Mio. EUR
MS

Mr. Michael Sen (57)

Chairman of the Supervisory Board · od 2023

509.000,00 EUR
SB

Ms. Stefanie Balling (56)

Vice Chairman of the Supervisory Board, Employee Representatives · od 2024

320.000,00 EUR
PW

Ms. Pascale Witz (58)

Independent Member of the Supervisory Board

299.000,00 EUR
MK

Dr. Marcus Kuhnert (57)

Independent Member of the Supervisory Board

297.000,00 EUR
SK

Mr. Shervin Korangy (51)

Independent Member of the Supervisory Board

245.000,00 EUR

Pogosto postavljena vprašanja o delnici Fresenius Medical Care

Fresenius Medical Care AG is a leading global provider of dialysis products, services, and solutions for patients with chronic kidney failure. The company's business model revolves around providing high-quality dialysis care to patients in over 120 countries. Fresenius Medical Care AG offers a comprehensive range of dialysis machines, dialyzers, and other related products to ensure efficient and effective treatment. Furthermore, the company operates a network of dialysis clinics, providing personalized care for patients worldwide. With a focus on innovation, research, and development, Fresenius Medical Care AG continuously strives to enhance patient outcomes and improve the overall quality of life for individuals with kidney disease.

Fresenius Medical Care AG is primarily active in the healthcare industry.

The main competitors of Fresenius Medical Care AG in the market are DaVita Inc., Baxter International Inc., and B. Braun Melsungen AG.

Fresenius Medical Care AG is a leading global healthcare company specializing in dialysis products and services. Established in 1996, it stemmed from the merger of Fresenius AG and National Medical Care. With its headquarters in Germany, the company has expanded its reach worldwide, operating in nearly 150 countries. Fresenius Medical Care AG is renowned for its expertise in renal therapy, offering innovative dialysis machines, dialyzers, and related medical supplies. As a market leader, it provides life-saving treatments to millions of people suffering from chronic kidney disease. The company's commitment to delivering high-quality care and advancing renal healthcare has made Fresenius Medical Care AG a trusted name in the medical industry.

Fresenius Medical Care AG, a leading healthcare company, has achieved significant milestones throughout its history. It pioneered the development of advanced dialysis products and services, revolutionizing the treatment of end-stage renal disease. The company has established a global presence, operating in over 120 countries and serving millions of patients worldwide. Additionally, Fresenius Medical Care AG has continuously expanded its business through strategic acquisitions and collaborations, strengthening its position as a market leader in dialysis care. With a commitment to research and development, the company has achieved breakthrough innovations in dialysis technology, enhancing patient outcomes and quality of life. Overall, Fresenius Medical Care AG’s impressive achievements have solidified its reputation as a trusted provider of renal therapies.

Fresenius Medical Care AG is primarily present in various countries and regions across the globe. With a strong global presence, the company operates in more than 150 countries and regions, including the United States, Germany, Asia-Pacific, Latin America, and Europe. Its widespread international network enables Fresenius Medical Care AG to provide advanced renal care products, services, and solutions to patients worldwide. As the global leader in dialysis and kidney care, Fresenius Medical Care AG continues to expand its reach and impact, ensuring quality healthcare for patients globally.

Fresenius Medical Care AG represents values of quality, innovation, and patient-centered care. With a dedicated corporate philosophy, the company focuses on providing life-saving dialysis products, therapies, and services to patients worldwide. The commitment to excellence, compassion, and continuous advancement in medical technology enables Fresenius Medical Care AG to enhance patients' quality of life and deliver optimal renal care. As a global leader in the field, Fresenius Medical Care AG maintains a strong emphasis on scientific research, sustainability, and delivering efficient healthcare solutions for patients suffering from chronic kidney diseases.

Analysts currently set an average price target of 45,79 EUR for the Fresenius Medical Care stock (median: 46,92 EUR), implying +8,2 % versus the latest price. The consensus is based on 27 analyst ratings.

Fresenius Medical Care Cenovna tarča analitikov 2026

27 analysts currently rate the Fresenius Medical Care stock: 11 recommend buying, 9 holding and 7 selling. For 2026, analysts expect Fresenius Medical Care to generate revenue of 19,36 Mrd. EUR and earnings per share of 4,09 EUR.

Fresenius Medical Care Cenovna tarča analitikov 2026

The Fresenius Medical Care share (FME.DE) is listed on 10 stock exchanges, including: XETRA (FME.DE), Frankfurt (FME.F), München (FME.MU), Düsseldorf (FME.DU), Hamburg (FME.HM), London (0H9X.L), SIX (Zürich) (FMEEUR.SW), Wien (FME.VI).

Fresenius Medical Care AG is a leading provider of products and services for the dialysis treatment of patients with kidney failure. The company is headquartered in Bad Homburg, Germany, and operates in over 120 countries worldwide. Fresenius Medical Care also operates its own dialysis centers and offers various other medical services. The business model of Fresenius Medical Care includes three business segments: dialysis products, services related to dialysis treatment, and the care of patients with chronic diseases. In the field of dialysis products, Fresenius Medical Care develops and produces a wide range of dialysis equipment and reagents. These products are sold to both their own dialysis centers and other medical facilities worldwide. Thanks to technological innovations in dialysis treatment, medical professionals can offer patients better outcomes and a higher quality of life. In the second business segment, Fresenius Medical Care provides services related to dialysis treatment. The company operates and manages its own dialysis centers and also provides the necessary medical professionals. Additionally, Fresenius Medical Care offers technical support and training for the use of their own dialysis products. These services are an important part of the business model as they ensure both the sales of their own products and the high-quality medical care of patients. A third business segment of Fresenius Medical Care is the care of patients with chronic diseases. Through the use of data analysis and telemedicine technologies, medical professionals from Fresenius Medical Care can actively care for patients - both online and through home visits. The goal is to improve the health of patients and avoid hospital stays. The business model of Fresenius Medical Care is based on preventive health care and support for people with chronic diseases such as kidney failure. By providing high-quality products and services and establishing a comprehensive patient care program, Fresenius Medical Care strengthens its position as a leading provider in dialysis treatment. In recent years, Fresenius Medical Care has also increased its investment in research and development of innovative treatment methods to continuously improve the quality of medical care for patients with chronic diseases. The extensive expertise in this field enables the development of new treatment modalities, including digital solutions, that benefit patients. Overall, Fresenius Medical Care is an innovative company specializing in the provision of products and services for dialysis treatment. By combining technological innovations, a comprehensive patient care program, and a constant focus on the needs of medical professionals in the global healthcare industry, the company relies on a forward-looking, promising business model in a sector of growing importance.

pričakovane prihodki za Fresenius Medical Care znašajo 19,36 Mrd. EUR. Ta vrednost temelji na trenutnih finančnih podatkih in odraža poslovno uspešnost podjetja.

pričakovane dobiček za Fresenius Medical Care znaša 1,17 Mrd. EUR. Čisti dobiček odraža donosnost podjetja po odbitku vseh stroškov.

Razmerje cena-dobiček (P/E) Fresenius Medical Care je trenutno 10,04. Razmerje P/E primerja trenutno ceno delnice z dobičkom na delnico in pomoči vlagateljem oceniti vrednost delnice Fresenius Medical Care.

Razmerje cena-prihodki (P/S) Fresenius Medical Care je trenutno 0,61. Razmerje P/S primerja tržno vrednost s celotnimi letnimi prihodki in služi kot kazalnik vrednotenja delnice Fresenius Medical Care.

Eulerpool ocena kvalitete za Fresenius Medical Care je 4/10.

ISIN Fresenius Medical Care je DE0005785802. ISIN (International Securities Identification Number) je svetovni edinstven identifikator za vrednostne papirje.

WKN Fresenius Medical Care je 578580. WKN (Wertpapierkennnummer) je šestmestna nemška oznaka za identifikacijo vrednostnih papirjev.

Ticker Fresenius Medical Care je FME.DE. Ticker simbol se uporablja za trgovanje z delnicami Fresenius Medical Care na borzi.

V zadnjih 12 mesecih je Fresenius Medical Care izplačala dividendo v višini 1,44 EUR . To ustreza dividendnemu donosu približno 3,50 %. Za naslednje 12 mesecev je pričakovati, da bo Fresenius Medical Care izplačala dividendo v višini 1,55 EUR.

Trenutna dividendna donosnost Fresenius Medical Care je 3,50 %.

Fresenius Medical Care izplačuje dividende, razdeljene v mesecih , , , .

Fresenius Medical Care je izplačevala dividende vsako leto v zadnjih 28 letih.

Za prihodnje 12 mesecev se pričakuje izplačilo dividend v višini 1,55 EUR. To ustreza dividendnemu donosu 3,66 %.

Fresenius Medical Care je uvrščena v sektor 'Zdravstvo'.

Da bi prejeli zadnjo dividendo Fresenius Medical Care od v višini 1,44 EUR, ste morali imeti delnico v portfelju pred ex-datumom dne .

Zadnja dividenda je bila izplačana dne .

V letu 2025 je bilo od Fresenius Medical Care izplačano 1,19 EUR kot dividende.

Dividende Fresenius Medical Care so izplačane v EUR.

Vse ključne kazalnike in poglobljeno analizo Fresenius Medical Care v detaljnem pregledu

Naša analiza delnic Fresenius Medical Care vključuje pomembne finančne kazalnike, kot so prihodki, dobiček, razmerje cena/dobiček (P/E), razmerje cena/prihodki (P/S), EBIT ter informacije o dividendah. Prav tako preučujemo aspekte, kot so delnice, tržna kapitalizacija, dolgovi, lastniški kapital in obveznosti Fresenius Medical Care. Če iščete podrobnejše informacije o teh temah, na naših podstraneh nudimo obsežne analize:

Fresenius Medical Care Delnica
Fresenius Medical Care Prihodki→
Fresenius Medical Care Delnica
Fresenius Medical Care Čisti dobiček→
Fresenius Medical Care Delnica
Fresenius Medical Care KGV→
Fresenius Medical Care Delnica
Fresenius Medical Care KUV→
Fresenius Medical Care Delnica
Fresenius Medical Care EBIT→
Fresenius Medical Care Delnica
Fresenius Medical Care Dividenda→
Fresenius Medical Care Delnica
Fresenius Medical Care Kupnje notranjih oseb→
Fresenius Medical Care Delnica
Fresenius Medical Care Delnice→
Fresenius Medical Care Delnica
Fresenius Medical Care Tržna kapitalizacija→
Fresenius Medical Care Delnica
Fresenius Medical Care Dolg→
Fresenius Medical Care Delnica
Fresenius Medical Care Obveznosti→
Fresenius Medical Care Delnica
Fresenius Medical Care Lastniški kapital→
Fresenius Medical Care Delnica
Fresenius Medical Care AAQS→
Fresenius Medical Care Delnica
Fresenius Medical Care Zaposleni→
Fresenius Medical Care Delnica
Fresenius Medical Care ROE→
Fresenius Medical Care Delnica
Fresenius Medical Care ROA→
Fresenius Medical Care Delnica
Fresenius Medical Care ROCE→
Fresenius Medical Care Delnica
Fresenius Medical Care News→
Fresenius Medical Care Delnica
Fresenius Medical Care Cenovna tarča analitikov→

Zdravstvo Delnice

Fresenius Medical CareFreliiFresenius SE & Co KGaAFredun PharmaceuticalsFrontier BiotechnologiesFrance Bed Holdings CoFuan Pharmaceutical Group CoForza InnovationsFuji Pharma CoFortress BiotechFujian Cosunter Pharmaceutical CoFortrea HoldingsVse delnice A–Z →